Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Evaluating the Effect of Il-27-Transfected Mesenchymal Stem Cells on Certain Histological and Immunological Parameters in a Mouse Model of Experimental Autoimmune Encephalomyelitis



Mojadadi MS1 ; Golmohammadi R2 ; Khanahmad H3 ; Gholami O4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran
  2. 2. Department of Anatomy, School of Medicine, Sabzevar University of Medical Sciences, Sabzevar, Iran
  3. 3. Department of Anatomical Sciences and Genetics, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  4. 4. Department of Physiology and Pharmacology, School of Medicine, Sabzevar University of Medical Sciences, Sabzevar, Iran

Source: Journal of Isfahan Medical School Published:2013

Abstract

Background: Mesenchymal stem cells (MSCs) by having immunomodulatory and neuroprotectivity properties could be a suitable candidate for the treatment of inflammatory and neurodegenerative diseases. Furthermore, by genetical manipulation, it is possible to potentiate the therapeutic characteristics of these cells. The aim of this study was to investigate the effect of IL-27-transfected MSCs in a mouse model of experimental autoimmune encephalomyelitis (EAE). Methods: MSCs were isolated from the bone marrow of C57BL/6 mice and were trnasfected with mouse IL-27 gene by using a lentiviral vector system. On days 15 and 22 post EAE induction, one million of these cells were injected to EAE-affected mice. Finally, all the mice were sacrificed; and histological and immunological assays were performed to investigate the myelin status and infiltration rate of immune cells into the central nervous system (CNS) tissues and measure certain cytokines, respectively. Findings: IL-27-transfected MSCs could ameliorate disease in the EAE-affected mice. Besides, they could diminish the infiltration rate of immune cells into the CNS, and inhibited the myelin destruction. Moreover, IL-27- transfected MSCs could enhance IL-4 and IL-10, and reduce IL-17 production from the EAE mice splenocytes. Conclusion: IL-27-transfected MSCs could be considered as a therapeutic tool for the treatment of inflammatory diseases including multiple sclerosis (MS). Changing dose and rout of administration, however, would be suggested to achieve better results.
Related Docs
View other Related Docs
1. Transplantation of Human Adipose-Derived Stem Cells Overexpressing Lif/Ifn-Β Promotes Recovery in Experimental Autoimmune Encephalomyelitis (Eae), Scientific Reports (2022)
2. Current Advances in Stem Cell Therapy in the Treatment of Multiple Sclerosis, Reviews in the Neurosciences (2023)
3. Therapeutic Effects of Extracellular Vesicles From Human Adipose-Derived Mesenchymal Stem Cells on Chronic Experimental Autoimmune Encephalomyelitis, Journal of Cellular Physiology (2020)
4. The Immunoregulatory and Neuroprotective Effects of Human Adipose Derived Stem Cells Overexpressing Il-11 and Il-13 in the Experimental Autoimmune Encephalomyelitis Mice, International Immunopharmacology (2020)
5. Impact of Intraventricular Human Adipose-Derived Stem Cells Transplantation With Pregnenolone Treatment on Remyelination of Corpus Callosum in a Rat Model of Multiple Sclerosis, Cell Journal (2022)
6. Transplantation of Human Adipose-Derived Stem Cells Enhances Remyelination in Lysolecithin-Induced Focal Demyelination of Rat Spinal Cord, Molecular Biotechnology (2014)
7. Co-Transplantation of Human Neurotrophic Factor Secreting Cells and Adipose-Derived Stem Cells in Rat Model of Multiple Sclerosis, Cell Journal (2018)
8. Application of Mesenchymal Stem Cells in Melanoma: A Potential Therapeutic Strategy for Delivery of Targeted Agents, Current Medicinal Chemistry (2016)
Experts (# of related papers)
View all Related Experts
Hossein Salehi (12)
Nazem Ghasemi (11)
Other Related Docs
9. Recent Advancements to Engineer Mesenchymal Stem Cells and Their Extracellular Vesicles for Targeting and Destroying Tumors, Progress in Biophysics and Molecular Biology (2023)
10. The Role of Distinct Subsets of Macrophages in the Pathogenesis of Ms and the Impact of Different Therapeutic Agents on These Populations, Frontiers in Immunology (2021)
11. Establishment of Experimental Autoimmune Encephalitis Model by Injection of Different Combination of Homogenized Brain Tissue of Rat With Cfa, Journal of Isfahan Medical School (2012)
12. Improvement of Remyelination in Demyelinated Corpus Callosum Using Human Adipose-Derived Stem Cells (Hadscs) and Pregnenolone in the Cuprizone Rat Model of Multiple Sclerosis, Journal of Molecular Neuroscience (2020)
13. The Frequency of Varicella-Zoster Virus Infection in Patients With Multiple Sclerosis Receiving Fingolimod, Journal of Neuroimmunology (2019)
14. Decreased Serum Levels of Interleukin-35 Among Multiple Sclerosis Patients May Be Related to Disease Progression, Journal of Biological Regulators and Homeostatic Agents (2018)
15. Can Plasma Exchange Therapy Induce Regulatory T Lymphocytes in Multiple Sclerosis Patients?, Clinical and Experimental Immunology (2012)
16. Effect of Leukemia Inhibitory Factor on the Myelinogenic Ability of Schwann-Like Cells Induced From Human Adipose-Derived Stem Cells, Cellular and Molecular Neurobiology (2013)
17. Evaluation of Edaravone Effects on the Differentiation of Human Adipose Derived Stem Cells Into Oligodendrocyte Cells in Multiple Sclerosis Disease in Rats, Life Sciences (2021)
18. Improvement of Myelin Ultrastructure After Transplantation of Human Adipose Tissue-Derived Stem Cell in Rat Multiple Sclerosis Model, Journal of Isfahan Medical School (2016)
19. Mesenchymal Stem Cell-Derived Extracellular Vesicles: A Novel Cell-Free Therapy, Immunological Investigations (2020)
20. Therapeutic Application of Multipotent Stem Cells, Journal of Cellular Physiology (2018)
21. Valproic Acid Effects on Human Adipose-Derived Stem Cell Differentiation Into Oligodendrocytes and Improved Remyelination in a Mouse Model of Multiple Sclerosis, International Journal of Developmental Biology (2023)
22. Cytokine Gene Expression in Newly Diagnosed Multiple Sclerosis Patients, Iranian Journal of Allergy, Asthma and Immunology (2015)
23. The Evaluation of Astaxanthin Effects on Differentiation of Human Adipose Derived Stem Cells Into Oligodendrocyte Precursor Cells, Avicenna Journal of Medical Biotechnology (2018)
24. Evaluation of in Vivo Lithium Chloride Effects As a Gsk3-Β Inhibitor on Human Adipose Derived Stem Cells Differentiation Into Oligodendrocytes and Re-Myelination in an Animal Model of Multiple Sclerosis, Molecular Biology Reports (2023)
25. Increased Serum Level of Il-37 in Patients With Multiple Sclerosis and Neuromyelitis Optica, Acta Neurologica Belgica (2015)
26. Multiple Sclerosis: Clinical Features, Pathophysiology, Neuroimaging and Future Therapies, Future Neurology (2009)
27. Interleukin-33 Plasma Levels in Patients With Relapsing-Remitting Multiple Sclerosis, Biomolecular Concepts (2017)
28. Immunoregulatory Properties of Human Bone Marrow Mesenchymal Stem Cells on T Lymphocyte Proliferation, Journal of Isfahan Medical School (2012)
29. Apamin As a Bbb Shuttle and Its Effects on T Cell Population During the Experimental Autoimmune Encephalomyelitis-Induced Model of Multiple Sclerosis, Neurotoxicity Research (2021)
30. The Role of Nk and Nkt Cells in the Pathogenesis and Improvement of Multiple Sclerosis Following Disease-Modifying Therapies, Health Science Reports (2022)
31. Comparison of Expression Levels of Mir-29B-3P and Mir-326 in T Helper-1 and T Helper-17 Cells Isolated From Responsive and Non-Responsive Relapsing-Remitting Multiple Sclerosis Patients Treated With Interferon-Beta, Iranian Journal of Allergy, Asthma and Immunology (2020)
32. Serum Level of Interleukin 36 in Patients With Multiple Sclerosis, Journal of Immunoassay and Immunochemistry (2018)
33. The Role of Immune Regulatory Molecules in Multiple Sclerosis, Journal of Neuroimmunology (2019)
34. Comparative Analysis of Apigenin-3 Acetate Versus Apigenin and Methyl-Prednisolone in Inhibiting Proliferation and Gene Expression of Th1 Cells in Multiple Sclerosis, Cell Journal (2023)
35. Microrna-92A Drives Th1 Responses in the Experimental Autoimmune Encephalomyelitis, Inflammation (2019)
36. The Levels of Soluble Forms of Cd21 and Cd83 in Multiple Sclerosis, Journal of Neuroimmunology (2018)
37. Multiple Sclerosis: Pathogenesis, Symptoms, Diagnoses and Cell-Based Therapy, Cell Journal (2017)
38. Regenerative Medicine in Covid-19 Treatment: Real Opportunities and Range of Promises, Stem Cell Reviews and Reports (2021)
39. Assessment of Ability of Human Adipose Derived Stem Cells for Long Term Overexpression of Il-11 and Il-13 As Therapeutic Cytokines, Cytotechnology (2020)
40. Il-27 Plasma Level in Relapsing Remitting Multiple Sclerosis Subjects: The Double-Faced Cytokine, Journal of Immunoassay and Immunochemistry (2016)
41. Human Placental Extract Attenuates Neurological Symptoms in the Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis-A Putative Approach in Ms Disease?, Autoimmunity Highlights (2020)
42. Microrna-29B Variants and Mxa Expression Change During Interferon Beta Therapy in Patients With Relapsing-Remitting Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2019)
43. Covid-19-Induced Stroke and the Potential of Using Mesenchymal Stem Cells-Derived Extracellular Vesicles in the Regulation of Neuroinflammation, Cellular and Molecular Neurobiology (2023)
44. Il-23 Plasma Level Measurement in Relapsing Remitting Multiple Sclerosis (Rrms) Patients Compared to Healthy Subjects, Immunological Investigations (2015)
45. Impact of Ifn-Β and Lif Overexpression on Human Adipose-Derived Stem Cells Properties, Journal of Cellular Physiology (2020)
46. Non-Viral Gene Transfer Into Murine Adipose Derived Mesenchymal Stem Cells: A Comparative Study of Different Non-Viral Methods, Gene Therapy and Molecular Biology (2013)
47. Comparison of Two Protocols for Induction of Differentiation of Human Adipose Derived Stem Cells Into Oligodendrocyte Progenitor Cells, Scientific Journal of Kurdistan University of Medical Sciences (2017)
48. Complement in Neurobiology, Frontiers in Bioscience (2011)
49. Administration of Stem Cells Against Cardiovascular Diseases With a Focus on Molecular Mechanisms: Current Knowledge and Prospects, Tissue and Cell (2023)